Trial Profile
The efficacy of omarigliptin in type 2 diabetic patients
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 30 Sep 2019
Price :
$35
*
At a glance
- Drugs Omarigliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 26 Sep 2019 Status changed from recruiting to active, no longer recruiting.
- 30 Mar 2017 New trial record